These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4637969)

  • 1. Use of drugs for unapproved indications: your legal responsibility.
    Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected item from the FDA drug bulletin. Use of drugs for unapproved indications: legal responsibility.
    Calif Med; 1972 Dec; 117(6):80-1. PubMed ID: 4635407
    [No Abstract]   [Full Text] [Related]  

  • 3. How does the FDA affect you and your practice?
    Novitch M
    Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served?
    Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306
    [No Abstract]   [Full Text] [Related]  

  • 5. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 6. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served?
    J Med Assoc State Ala; 1972 Sep; 42(3):200-12. PubMed ID: 5070864
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs and deterrence: Rockefeller's Drug Legislation].
    Trilling C
    Quad Criminol Clin; 1974; 16(1):61-85. PubMed ID: 4406576
    [No Abstract]   [Full Text] [Related]  

  • 12. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 13. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 14. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 15. "Off-label" psychotropic medication use in children.
    Regan J; Alderson A
    Tenn Med; 2003 Sep; 96(9):429-31. PubMed ID: 14513532
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug control in the USA].
    Gram LF
    Ugeskr Laeger; 1973 Nov; 135(47):2557-60. PubMed ID: 4782892
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and effectiveness of over-the-counter drugs: the FDA's OTC drug review.
    Pediatrics; 1977 Feb; 59(2):309-11. PubMed ID: 834521
    [No Abstract]   [Full Text] [Related]  

  • 18. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "unapproved use" of approved drugs.
    Wilcox DP
    Tex Med; 1980 Sep; 76(9):66-7. PubMed ID: 7434249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.